Loading...
•
Jun 30, 2020
Pediatrix Q2 2020 Earnings Report
Results from continuing operations reflected significant recovery in the second half of the quarter following initial disruption from COVID-19.
Key Takeaways
MEDNAX reported a net loss of $8.03 per share but an adjusted EPS of $0.32 from continuing operations. Net revenue was $509 million, net income was $8 million, and adjusted EBITDA was $65 million for the second quarter of 2020.
Net revenue for the quarter was $509 million.
Net income for the quarter was $8 million.
Adjusted EPS from continuing operations was $0.32.
The company is maintaining its outlook for the initial financial profile of Pediatrix Medical Group.
Forward Guidance
The Company anticipates full normalization of patient volumes across all service lines, pending the pandemic.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...